BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.68
−0.37%Margins
Gross margin
69.8%
EBITDA margin
-591.0%
EBIT margin
-876.3%
Net margin
-574.3%
FCF margin
-583.8%
-58.3%
Return on equity
-24.0%
Return on assets
-56.4%
Return on invested capital
0.04x
Asset turnover
-$8.1M
Cash from operations
$2.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026